These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 36398988

  • 1. Examining the Role for Donor-specific Antibody Testing in Simultaneous Liver-kidney Transplantation: A Single-center Analysis of Outcomes.
    Das A, Rocque B, Remulla D, Raza M, Barbetta A, Bangerth S, Goldbeck C, Maw TT, Kim J, Kwon Y, Emamaullee J.
    Transplantation; 2023 May 01; 107(5):1115-1123. PubMed ID: 36398988
    [Abstract] [Full Text] [Related]

  • 2. Association between post-transplant donor-specific antibodies and recipient outcomes in simultaneous liver-kidney transplant recipients: single-center, cohort study.
    Yazawa M, Cseprekal O, Helmick RA, Talwar M, Balaraman V, Podila PSB, Agbim UA, Maliakkal B, Fossey S, Satapathy SK, Sumida K, Kovesdy CP, Nair S, Eason JD, Molnar MZ.
    Transpl Int; 2020 Feb 01; 33(2):202-215. PubMed ID: 31647143
    [Abstract] [Full Text] [Related]

  • 3. Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver-kidney transplant recipients.
    Yazawa M, Cseprekal O, Helmick RA, Talwar M, Balaraman V, Podila PSB, Fossey S, Satapathy SK, Eason JD, Molnar MZ.
    Ren Fail; 2020 Nov 01; 42(1):40-47. PubMed ID: 31875761
    [Abstract] [Full Text] [Related]

  • 4. Lack of Association between Pretransplant Donor-Specific Antibodies and Posttransplant Kidney Outcomes in Simultaneous Liver-Kidney Transplant Recipients with Rabbit Anti-Thymocyte Globulin Induction and Steroid-Free Protocol.
    Yazawa M, Cseprekal O, Helmick RA, Talwar M, Balaraman V, Podila PSB, Agbim UA, Maliakkal B, Fossey S, Satapathy SK, Sumida K, Kovesdy CP, Nair S, Eason JD, Molnar MZ.
    Nephron; 2020 Nov 01; 144(3):126-137. PubMed ID: 32007998
    [Abstract] [Full Text] [Related]

  • 5. Crossmatch, Donor-specific Antibody Testing, and Immunosuppression in Simultaneous Liver and Kidney Transplantation: A Review.
    Das A, Taner T, Kim J, Emamaullee J.
    Transplantation; 2021 Dec 01; 105(12):e285-e291. PubMed ID: 33606486
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Alloantibodies after simultaneous liver-kidney transplant: A story of primary nonfunction, retransplantation, and antibody-mediated rejection.
    Ramon DS, Troop DM, Kinard TN, Jadlowiec CC, Ryan MS, Hewitt WR, Olsen LG, Jaramillo A, Taner T, Heilman RL.
    Am J Transplant; 2022 Mar 01; 22(3):977-985. PubMed ID: 34882942
    [Abstract] [Full Text] [Related]

  • 8. Impact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant Recipients.
    Lee H, Lee H, Eum SH, Ko EJ, Min JW, Oh EJ, Yang CW, Chung BH.
    Ann Lab Med; 2023 Jul 01; 43(4):364-374. PubMed ID: 36843405
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
    Olszowska-Zaremba N, Gozdowska J, Zagożdżon R.
    Transpl Immunol; 2022 Oct 01; 74():101672. PubMed ID: 35868613
    [Abstract] [Full Text] [Related]

  • 10. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D, Bach C, Staudner C, Böger CA, Bergler T, Banas B, Spriewald BM.
    Nephrol Dial Transplant; 2017 Apr 01; 32(4):730-737. PubMed ID: 28339671
    [Abstract] [Full Text] [Related]

  • 11. Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants.
    Dar W, Agarwal A, Watkins C, Gebel HM, Bray RA, Kokko KE, Pearson TC, Knechtle SJ.
    Am J Transplant; 2011 Apr 01; 11(4):841-7. PubMed ID: 21446981
    [Abstract] [Full Text] [Related]

  • 12. Rapid reduction of high-level pre-formed donor-specific antibodies after simultaneous liver-kidney transplantation: a report of two cases.
    Lai C, Newman A, Mawson J, Abou-Daher F, Watson N, Majumdar A, Wyburn K, Chadban S, Gracey D.
    BMC Nephrol; 2020 Feb 12; 21(1):47. PubMed ID: 32050922
    [Abstract] [Full Text] [Related]

  • 13. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
    Jalalonmuhali M, Carroll RP, Tsiopelas E, Clayton P, Coates PT.
    Hum Immunol; 2020 Jul 12; 81(7):323-329. PubMed ID: 32327243
    [Abstract] [Full Text] [Related]

  • 14. Avoiding Futility in Simultaneous Liver-kidney Transplantation: Analysis of 331 Consecutive Patients Listed for Dual Organ Replacement.
    Lunsford KE, Bodzin AS, Markovic D, Zarrinpar A, Kaldas FM, Gritsch HA, Xia V, Farmer DG, Danovitch GM, Hiatt JR, Busuttil RW, Agopian VG.
    Ann Surg; 2017 May 12; 265(5):1016-1024. PubMed ID: 27232249
    [Abstract] [Full Text] [Related]

  • 15. The Utility of Donor-specific Antibody Monitoring and the Role of Kidney Biopsy in Simultaneous Liver and Kidney Recipients With De Novo Donor-specific Antibodies.
    Parajuli S, Aziz F, Blazel J, Muth BL, Garg N, Mohamed M, Rice J, Mezrich JD, Hidalgo LG, Mandelbrot D.
    Transplantation; 2021 Jul 01; 105(7):1548-1555. PubMed ID: 32732618
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of Highly Sensitized Patients Undergoing Simultaneous Liver and Kidney Transplantation: A Single-Center Experience With Desensitization.
    Steggerda JA, Kang A, Pan SH, Sundaram V, Nissen NN, Klein AS, Todo T, Annamalai A, Vo A, Jordan SC, Kim IK.
    Transplant Proc; 2017 Jul 01; 49(6):1394-1401. PubMed ID: 28736013
    [Abstract] [Full Text] [Related]

  • 17. Impact of Donor Specific HLA Antibody Monitoring After Kidney Transplantation.
    Rao S, Ghanta M, Lee IJ, Gillespie A, Parekh HK, Geier SS, Zeng X, Karachristos A, Lau KN, Karhadkar S, Di Carlo A, Sifontis NM, Constantinescu S.
    Clin Transpl; 2014 Jul 01; ():143-51. PubMed ID: 26281139
    [Abstract] [Full Text] [Related]

  • 18. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
    Cuevas E, Arreola-Guerra JM, Hernández-Méndez EA, Salcedo I, Castelán N, Uribe-Uribe NO, Vilatobá M, Contreras-Saldívar AG, Sánchez-Cedillo AI, Ramírez JB, de Rungs D, Granados J, Morales-Buenrostro LE, Alberú J.
    Nephrol Dial Transplant; 2016 Oct 01; 31(10):1738-45. PubMed ID: 27220757
    [Abstract] [Full Text] [Related]

  • 19. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation.
    Huang Y, Ramon D, Luan FL, Sung R, Samaniego M.
    Clin Transpl; 2012 Oct 01; ():247-56. PubMed ID: 23721029
    [Abstract] [Full Text] [Related]

  • 20. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct 01; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.